WIEDER, Thomas,HAHN, Matthias,BRENNER, Ellen,BRAUMÜLLER, Heidi,BRAUNGART, Kilian,ASSMANN, Sonja,RÖCKEN, Martin
申请号：
EP13826993.1
公开号：
EP2931375A1
申请日:
2013.12.11
申请国别(地区):
EP
年份:
2015
代理人:
摘要：
The present invention relates to a combination of at least two different substances, one of which activates the STAT1-signalling cascade and the other of which activates the TNFR1/CD95-signalling cascade in order to induce permanent growth arrest&mdashi.e. senescence&mdashin pre-malignant or malignant tumors or tumor cells. This induction of permanent growth arrest does not depend on cytotoxicity and does not primarily attempt to kill tumor cells, although this may occur. The induction serves to treat and/or prevent tumors by permanent growth arrest. The combination is used for therapeutic or preventative senescence induction in tumors, in which the STAT1- and TNFR1/CD95-signalling cascade can be activated and in which p16lnk4a is present. The invention transfers tumor cells and, contrary to many other therapies, the tumor stem cells, into permanent growth arrest.
